Study of Relapsed/ Refractory B-cell Non- Hodgkin Lymphoma

Clinical trial NCT07125872 · RECRUITING

Trial details

NCT number: NCT07125872
Sponsor: ImmunityBio, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Relapsed B-Cell Non Hodgkin Lymphoma

Start date: 2025-11-11
Primary completion: 2027-05-25
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.